FDA Inspection 1107088 — Vitalant (Harmar - Fox Chapel Area)

Vitalant (Harmar - Fox Chapel Area) — FEI 2529059

The FDA completed an inspection of Vitalant (Harmar - Fox Chapel Area) on September 10, 2019 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 10, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Pittsburgh, PA (United States)